Workflow
TSX-V: TT Signing of the Asset Purchase Agreement for Two Gold Projects
Thenewswire· 2025-10-20 11:47
 October 20, 2025 – TheNewswire - Vancouver, BC - Total Metals Corp. (“Total Metals” or the “Company”) (TSX-V: TT) (FSE: O4N) is pleased to announce that it has entered into a definitive Asset Purchase Agreement (the “Agreement”) with McFarlane Lake Mining Limited (“McFarlane”) pursuant to which the Company will acquire 100% of McFarlane’s right, title, and interest in the High Lake and West Hawk Lake gold projects located near Kenora, Ontario (the “Transaction”).Under the terms of the Agreement, Total Met ...
Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline
Accessnewswire· 2025-10-20 11:45
FORT LAUDERDALE, FL / ACCESS Newswire / October 20, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company focused on innovative and affordable healthcare solutions, today announced the commercial launch of generic Doxycycline in Canada. This strategic move strengthens the Company's footprint in the Canadian growing antibiotic sector. ...
Prismo Metals Announces Private Placement and Ripsey Gold Project Overlimit Silver Assay Results
Thenewswire· 2025-10-20 11:45
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia – TheNewswire - October 20th, 2025 – Prismo Metals Inc. (the “Company”) (CSE: PRIZ) (OTCQB: PMOMF) is pleased to announce a non-brokered private placement (the “Private Placement”) of 12.5 million units of the Company (“Units”) at an issue price of $0.10 per Unit for minimum gross proceeds of $1,250,000. Each Unit will consist of one common share in the capital of the Company (a “Sh ...
Alibaba Leads Goldman's Top Chinese Picks For Global Growth
Benzinga· 2025-10-20 11:43
Core Insights - Goldman Sachs recommends investors focus on Chinese companies expanding internationally, driven by a weaker yuan, cost advantages, and China's robust global supply chains as growth catalysts [1] Group 1: Investment Opportunities - Goldman Sachs identified 25 top picks, including Alibaba Group Holding Ltd, Contemporary Amperex Technology Co Ltd, and BYD Co Ltd, as key beneficiaries of the "going global" trend [1] - These companies, spanning e-commerce, capital goods, and healthcare, have gained nearly 40% year-to-date, outperforming the Hang Seng Index's 29% and the CSI 300 Index's 16% rise [2] Group 2: Earnings Growth Projections - The bank expects overseas expansion to accelerate earnings growth by about 1.5% annually through 2028 as firms diversify beyond China's saturated domestic market [3] - Alibaba's overseas revenue doubled to 13% in 2023 from 7% in 2021, while CATL's increased to 30% from 21%, indicating rising global competitiveness [3] Group 3: Market Dynamics and Risks - Goldman acknowledged that potential 100% U.S. tariffs under Trump's trade agenda could reduce short-term profits by around 10%, but international diversification should mitigate this impact over time [4] Group 4: Alibaba's Performance and Projections - Alibaba's stock gained 97% year-to-date, significantly outperforming the NYSE Composite index's over 12% returns, driven by its cloud unit and AI model integration [5] - Goldman Sachs raised its cloud revenue growth forecasts to 31–38% through fiscal 2028, citing advancements in multimodal AI models and a diversified chip supply [6] - Daiwa Securities projected Alibaba Cloud revenue to climb 30% year-over-year in the second quarter of fiscal 2026, with operating losses expected to peak soon [7]
Stock markets surge for fourth day; Sensex jumps over 411 points
The Hindu· 2025-10-20 11:43
Equity benchmark indices Sensex and Nifty ended higher on Monday (October 20, 2025), taking their winning run to the fourth day in a row, driven by buying in blue-chip Reliance Industries and sustained foreign fund inflows. A sharp rally in global markets also added to the markets' optimism. The 30-share BSE Sensex jumped 411.18 points or 0.49% to settle at 84,363.37. During the day, it zoomed 704.37 points or 0.83% to 84,656.56. The 50-share NSE Nifty surged 133.30 points or 0.52% to 25,843.15. From the Se ...
Gold market analysis for October 20 - key intra-day price entry levels for active traders
KITCO· 2025-10-20 11:41
Core Insights - Jim Wyckoff has over 25 years of experience in stock, financial, and commodity markets, including roles as a financial journalist and market analyst [1][2] - He has covered all futures markets traded in the U.S. and has worked with various financial news and advisory services [1][2] Company and Industry Summary - Jim Wyckoff operates the "Jim Wyckoff on the Markets" analytical, educational, and trading advisory service, providing insights into market trends [2] - He has held positions as a technical analyst for Dow Jones Newswires and as a senior market analyst with TraderPlanet.com, showcasing his expertise in market analysis [2] - Wyckoff is also a consultant for the "Pro Farmer" agricultural advisory service, indicating his involvement in agricultural market analysis [2] - He was the head equities analyst at CapitalistEdge.com, further emphasizing his extensive background in equity markets [2] - Daily market updates and technical analysis are provided by Wyckoff on Kitco.com, highlighting his ongoing engagement with market participants [3]
Cooper Cos. Stock Rises as Report Says Activist Investor Takes Stake
Barrons· 2025-10-20 11:41
Jana Partners plans to push for strategic alternatives at Cooper, The Wall Street Journal reports. ...
Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders
Globenewswire· 2025-10-20 11:41
Vancouver, Canada, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the publication of a U.S. patent application by the United States Patent and Trademark Office (USPTO) for its innovative combination therapy of 5-methoxy-2-aminoindane (MEAI) and N-Acylethanolamines, s ...
SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders
Globenewswire· 2025-10-20 11:41
TEL AVIV, Israel, Oct. 20, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that its collaboration with Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind”) has led to the publication of a U.S. patent application by the United States Patent and Trademark Office. The patent relates to an innovative combin ...
This KLA Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Ally Financial (NYSE:ALLY), Apollo Comml Real Est (NYSE:ARI)
Benzinga· 2025-10-20 11:38
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.Considering buying KLAC stock? Here’s what analysts think: Read This Next: Photo via ShutterstockLoading...Loading... ...